[Experience with bencyclane in neurological diseases].
D000328:Adult; D000368:Aged; D000700:Analgesics; D002493:Central Nervous System Diseases / Q000188:drug therapy; D003508:Cycloheptanes / Q000627:therapeutic use*; D004357:Drug Synergism; D005650:Fumarates / Q000627:therapeutic use; D006220:Haloperidol / Q000494:pharmacology; D006261:Headache / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy
D000700:Analgesics; D003508:Cycloheptanes; D005650:Fumarates; D010276:Parasympatholytics; D011437:Propylamines; D006220:Haloperidol
Erfahrungen mit Bencyclan bei neurologischen Erkrankungen.